Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. is set to hold a Board meeting on October 25, 2024, to review and approve the company’s third-quarter financial results up to September 30, 2024. This upcoming announcement is expected to provide investors with updated information on the company’s performance and future outlook.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
